The zebrafish is an important and widely used vertebrate model organism in scientific research, for example in drug development, in particular pre-clinical development. It is also notable for its regenerative abilities, and has been modified by researchers to produce many transgenic strains.
This report contains market size and forecasts of Zebrafish Disease Models in Global, including the following market information:
Global Zebrafish Disease Models Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Zebrafish Disease Models market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Epilepsy Model Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Zebrafish Disease Models include Shanghai Model Organisms Center, Inc., ZeClinics, InVivo Biosystems, Biobide, Pentagrit, Evotec, Aurigene Pharmaceutical Services, Ikan Biotech and Bioreperia, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Publisher has surveyed the Zebrafish Disease Models companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Zebrafish Disease Models Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Zebrafish Disease Models Market Segment Percentages, by Type, 2021 (%)
Epilepsy Model
Parkinson Disease Model
Retinal Degeneration Model
Metabolic Disorders and Obesity Model
Global Zebrafish Disease Models Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Zebrafish Disease Models Market Segment Percentages, by Application, 2021 (%)
Pharmaceutical
Biotechnology
Global Zebrafish Disease Models Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Zebrafish Disease Models Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Zebrafish Disease Models revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Zebrafish Disease Models revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Shanghai Model Organisms Center, Inc.
ZeClinics
InVivo Biosystems
Biobide
Pentagrit
Evotec
Aurigene Pharmaceutical Services
Ikan Biotech
Bioreperia
Hangzhou Hunter Biotechnology Co., Ltd.
YSY BIOTECH
Eze-Rinka
INVENesis
FEIFAN TEST
Charles River Laboratories
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Zebrafish Disease Models Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Zebrafish Disease Models Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Zebrafish Disease Models Overall Market Size
2.1 Global Zebrafish Disease Models Market Size: 2021 VS 2028
2.2 Global Zebrafish Disease Models Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Zebrafish Disease Models Players in Global Market
3.2 Top Global Zebrafish Disease Models Companies Ranked by Revenue
3.3 Global Zebrafish Disease Models Revenue by Companies
3.4 Top 3 and Top 5 Zebrafish Disease Models Companies in Global Market, by Revenue in 2021
3.5 Global Companies Zebrafish Disease Models Product Type
3.6 Tier 1, Tier 2 and Tier 3 Zebrafish Disease Models Players in Global Market
3.6.1 List of Global Tier 1 Zebrafish Disease Models Companies
3.6.2 List of Global Tier 2 and Tier 3 Zebrafish Disease Models Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Zebrafish Disease Models Market Size Markets, 2021 & 2028
4.1.2 Epilepsy Model
4.1.3 Parkinson Disease Model
4.1.4 Retinal Degeneration Model
4.1.5 Metabolic Disorders and Obesity Model
4.2 By Type - Global Zebrafish Disease Models Revenue & Forecasts
4.2.1 By Type - Global Zebrafish Disease Models Revenue, 2017-2022
4.2.2 By Type - Global Zebrafish Disease Models Revenue, 2023-2028
4.2.3 By Type - Global Zebrafish Disease Models Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Zebrafish Disease Models Market Size, 2021 & 2028
5.1.2 Pharmaceutical
5.1.3 Biotechnology
5.2 By Application - Global Zebrafish Disease Models Revenue & Forecasts
5.2.1 By Application - Global Zebrafish Disease Models Revenue, 2017-2022
5.2.2 By Application - Global Zebrafish Disease Models Revenue, 2023-2028
5.2.3 By Application - Global Zebrafish Disease Models Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Zebrafish Disease Models Market Size, 2021 & 2028
6.2 By Region - Global Zebrafish Disease Models Revenue & Forecasts
6.2.1 By Region - Global Zebrafish Disease Models Revenue, 2017-2022
6.2.2 By Region - Global Zebrafish Disease Models Revenue, 2023-2028
6.2.3 By Region - Global Zebrafish Disease Models Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Zebrafish Disease Models Revenue, 2017-2028
6.3.2 US Zebrafish Disease Models Market Size, 2017-2028
6.3.3 Canada Zebrafish Disease Models Market Size, 2017-2028
6.3.4 Mexico Zebrafish Disease Models Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Zebrafish Disease Models Revenue, 2017-2028
6.4.2 Germany Zebrafish Disease Models Market Size, 2017-2028
6.4.3 France Zebrafish Disease Models Market Size, 2017-2028
6.4.4 U.K. Zebrafish Disease Models Market Size, 2017-2028
6.4.5 Italy Zebrafish Disease Models Market Size, 2017-2028
6.4.6 Russia Zebrafish Disease Models Market Size, 2017-2028
6.4.7 Nordic Countries Zebrafish Disease Models Market Size, 2017-2028
6.4.8 Benelux Zebrafish Disease Models Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Zebrafish Disease Models Revenue, 2017-2028
6.5.2 China Zebrafish Disease Models Market Size, 2017-2028
6.5.3 Japan Zebrafish Disease Models Market Size, 2017-2028
6.5.4 South Korea Zebrafish Disease Models Market Size, 2017-2028
6.5.5 Southeast Asia Zebrafish Disease Models Market Size, 2017-2028
6.5.6 India Zebrafish Disease Models Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Zebrafish Disease Models Revenue, 2017-2028
6.6.2 Brazil Zebrafish Disease Models Market Size, 2017-2028
6.6.3 Argentina Zebrafish Disease Models Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Zebrafish Disease Models Revenue, 2017-2028
6.7.2 Turkey Zebrafish Disease Models Market Size, 2017-2028
6.7.3 Israel Zebrafish Disease Models Market Size, 2017-2028
6.7.4 Saudi Arabia Zebrafish Disease Models Market Size, 2017-2028
6.7.5 UAE Zebrafish Disease Models Market Size, 2017-2028
7 Players Profiles
7.1 Shanghai Model Organisms Center, Inc.
7.1.1 Shanghai Model Organisms Center, Inc. Corporate Summary
7.1.2 Shanghai Model Organisms Center, Inc. Business Overview
7.1.3 Shanghai Model Organisms Center, Inc. Zebrafish Disease Models Major Product Offerings
7.1.4 Shanghai Model Organisms Center, Inc. Zebrafish Disease Models Revenue in Global Market (2017-2022)
7.1.5 Shanghai Model Organisms Center, Inc. Key News
7.2 ZeClinics
7.2.1 ZeClinics Corporate Summary
7.2.2 ZeClinics Business Overview
7.2.3 ZeClinics Zebrafish Disease Models Major Product Offerings
7.2.4 ZeClinics Zebrafish Disease Models Revenue in Global Market (2017-2022)
7.2.5 ZeClinics Key News
7.3 InVivo Biosystems
7.3.1 InVivo Biosystems Corporate Summary
7.3.2 InVivo Biosystems Business Overview
7.3.3 InVivo Biosystems Zebrafish Disease Models Major Product Offerings
7.3.4 InVivo Biosystems Zebrafish Disease Models Revenue in Global Market (2017-2022)
7.3.5 InVivo Biosystems Key News
7.4 Biobide
7.4.1 Biobide Corporate Summary
7.4.2 Biobide Business Overview
7.4.3 Biobide Zebrafish Disease Models Major Product Offerings
7.4.4 Biobide Zebrafish Disease Models Revenue in Global Market (2017-2022)
7.4.5 Biobide Key News
7.5 Pentagrit
7.5.1 Pentagrit Corporate Summary
7.5.2 Pentagrit Business Overview
7.5.3 Pentagrit Zebrafish Disease Models Major Product Offerings
7.5.4 Pentagrit Zebrafish Disease Models Revenue in Global Market (2017-2022)
7.5.5 Pentagrit Key News
7.6 Evotec
7.6.1 Evotec Corporate Summary
7.6.2 Evotec Business Overview
7.6.3 Evotec Zebrafish Disease Models Major Product Offerings
7.6.4 Evotec Zebrafish Disease Models Revenue in Global Market (2017-2022)
7.6.5 Evotec Key News
7.7 Aurigene Pharmaceutical Services
7.7.1 Aurigene Pharmaceutical Services Corporate Summary
7.7.2 Aurigene Pharmaceutical Services Business Overview
7.7.3 Aurigene Pharmaceutical Services Zebrafish Disease Models Major Product Offerings
7.7.4 Aurigene Pharmaceutical Services Zebrafish Disease Models Revenue in Global Market (2017-2022)
7.7.5 Aurigene Pharmaceutical Services Key News
7.8 Ikan Biotech
7.8.1 Ikan Biotech Corporate Summary
7.8.2 Ikan Biotech Business Overview
7.8.3 Ikan Biotech Zebrafish Disease Models Major Product Offerings
7.8.4 Ikan Biotech Zebrafish Disease Models Revenue in Global Market (2017-2022)
7.8.5 Ikan Biotech Key News
7.9 Bioreperia
7.9.1 Bioreperia Corporate Summary
7.9.2 Bioreperia Business Overview
7.9.3 Bioreperia Zebrafish Disease Models Major Product Offerings
7.9.4 Bioreperia Zebrafish Disease Models Revenue in Global Market (2017-2022)
7.9.5 Bioreperia Key News
7.10 Hangzhou Hunter Biotechnology Co., Ltd.
7.10.1 Hangzhou Hunter Biotechnology Co., Ltd. Corporate Summary
7.10.2 Hangzhou Hunter Biotechnology Co., Ltd. Business Overview
7.10.3 Hangzhou Hunter Biotechnology Co., Ltd. Zebrafish Disease Models Major Product Offerings
7.10.4 Hangzhou Hunter Biotechnology Co., Ltd. Zebrafish Disease Models Revenue in Global Market (2017-2022)
7.10.5 Hangzhou Hunter Biotechnology Co., Ltd. Key News
7.11 YSY BIOTECH
7.11.1 YSY BIOTECH Corporate Summary
7.11.2 YSY BIOTECH Business Overview
7.11.3 YSY BIOTECH Zebrafish Disease Models Major Product Offerings
7.11.4 YSY BIOTECH Zebrafish Disease Models Revenue in Global Market (2017-2022)
7.11.5 YSY BIOTECH Key News
7.12 Eze-Rinka
7.12.1 Eze-Rinka Corporate Summary
7.12.2 Eze-Rinka Business Overview
7.12.3 Eze-Rinka Zebrafish Disease Models Major Product Offerings
7.12.4 Eze-Rinka Zebrafish Disease Models Revenue in Global Market (2017-2022)
7.12.5 Eze-Rinka Key News
7.13 INVENesis
7.13.1 INVENesis Corporate Summary
7.13.2 INVENesis Business Overview
7.13.3 INVENesis Zebrafish Disease Models Major Product Offerings
7.13.4 INVENesis Zebrafish Disease Models Revenue in Global Market (2017-2022)
7.13.5 INVENesis Key News
7.14 FEIFAN TEST
7.14.1 FEIFAN TEST Corporate Summary
7.14.2 FEIFAN TEST Business Overview
7.14.3 FEIFAN TEST Zebrafish Disease Models Major Product Offerings
7.14.4 FEIFAN TEST Zebrafish Disease Models Revenue in Global Market (2017-2022)
7.14.5 FEIFAN TEST Key News
7.15 Charles River Laboratories
7.15.1 Charles River Laboratories Corporate Summary
7.15.2 Charles River Laboratories Business Overview
7.15.3 Charles River Laboratories Zebrafish Disease Models Major Product Offerings
7.15.4 Charles River Laboratories Zebrafish Disease Models Revenue in Global Market (2017-2022)
7.15.5 Charles River Laboratories Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Zebrafish Disease Models Market Opportunities & Trends in Global Market
Table 2. Zebrafish Disease Models Market Drivers in Global Market
Table 3. Zebrafish Disease Models Market Restraints in Global Market
Table 4. Key Players of Zebrafish Disease Models in Global Market
Table 5. Top Zebrafish Disease Models Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Zebrafish Disease Models Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Zebrafish Disease Models Revenue Share by Companies, 2017-2022
Table 8. Global Companies Zebrafish Disease Models Product Type
Table 9. List of Global Tier 1 Zebrafish Disease Models Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Zebrafish Disease Models Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Zebrafish Disease Models Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Zebrafish Disease Models Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Zebrafish Disease Models Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application - Global Zebrafish Disease Models Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Zebrafish Disease Models Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Zebrafish Disease Models Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region - Global Zebrafish Disease Models Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Zebrafish Disease Models Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Zebrafish Disease Models Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Zebrafish Disease Models Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Zebrafish Disease Models Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Zebrafish Disease Models Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Zebrafish Disease Models Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Zebrafish Disease Models Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Zebrafish Disease Models Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Zebrafish Disease Models Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Zebrafish Disease Models Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Zebrafish Disease Models Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Zebrafish Disease Models Revenue, (US$, Mn), 2023-2028
Table 30. Shanghai Model Organisms Center, Inc. Corporate Summary
Table 31. Shanghai Model Organisms Center, Inc. Zebrafish Disease Models Product Offerings
Table 32. Shanghai Model Organisms Center, Inc. Zebrafish Disease Models Revenue (US$, Mn), (2017-2022)
Table 33. ZeClinics Corporate Summary
Table 34. ZeClinics Zebrafish Disease Models Product Offerings
Table 35. ZeClinics Zebrafish Disease Models Revenue (US$, Mn), (2017-2022)
Table 36. InVivo Biosystems Corporate Summary
Table 37. InVivo Biosystems Zebrafish Disease Models Product Offerings
Table 38. InVivo Biosystems Zebrafish Disease Models Revenue (US$, Mn), (2017-2022)
Table 39. Biobide Corporate Summary
Table 40. Biobide Zebrafish Disease Models Product Offerings
Table 41. Biobide Zebrafish Disease Models Revenue (US$, Mn), (2017-2022)
Table 42. Pentagrit Corporate Summary
Table 43. Pentagrit Zebrafish Disease Models Product Offerings
Table 44. Pentagrit Zebrafish Disease Models Revenue (US$, Mn), (2017-2022)
Table 45. Evotec Corporate Summary
Table 46. Evotec Zebrafish Disease Models Product Offerings
Table 47. Evotec Zebrafish Disease Models Revenue (US$, Mn), (2017-2022)
Table 48. Aurigene Pharmaceutical Services Corporate Summary
Table 49. Aurigene Pharmaceutical Services Zebrafish Disease Models Product Offerings
Table 50. Aurigene Pharmaceutical Services Zebrafish Disease Models Revenue (US$, Mn), (2017-2022)
Table 51. Ikan Biotech Corporate Summary
Table 52. Ikan Biotech Zebrafish Disease Models Product Offerings
Table 53. Ikan Biotech Zebrafish Disease Models Revenue (US$, Mn), (2017-2022)
Table 54. Bioreperia Corporate Summary
Table 55. Bioreperia Zebrafish Disease Models Product Offerings
Table 56. Bioreperia Zebrafish Disease Models Revenue (US$, Mn), (2017-2022)
Table 57. Hangzhou Hunter Biotechnology Co., Ltd. Corporate Summary
Table 58. Hangzhou Hunter Biotechnology Co., Ltd. Zebrafish Disease Models Product Offerings
Table 59. Hangzhou Hunter Biotechnology Co., Ltd. Zebrafish Disease Models Revenue (US$, Mn), (2017-2022)
Table 60. YSY BIOTECH Corporate Summary
Table 61. YSY BIOTECH Zebrafish Disease Models Product Offerings
Table 62. YSY BIOTECH Zebrafish Disease Models Revenue (US$, Mn), (2017-2022)
Table 63. Eze-Rinka Corporate Summary
Table 64. Eze-Rinka Zebrafish Disease Models Product Offerings
Table 65. Eze-Rinka Zebrafish Disease Models Revenue (US$, Mn), (2017-2022)
Table 66. INVENesis Corporate Summary
Table 67. INVENesis Zebrafish Disease Models Product Offerings
Table 68. INVENesis Zebrafish Disease Models Revenue (US$, Mn), (2017-2022)
Table 69. FEIFAN TEST Corporate Summary
Table 70. FEIFAN TEST Zebrafish Disease Models Product Offerings
Table 71. FEIFAN TEST Zebrafish Disease Models Revenue (US$, Mn), (2017-2022)
Table 72. Charles River Laboratories Corporate Summary
Table 73. Charles River Laboratories Zebrafish Disease Models Product Offerings
Table 74. Charles River Laboratories Zebrafish Disease Models Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Zebrafish Disease Models Segment by Type in 2021
Figure 2. Zebrafish Disease Models Segment by Application in 2021
Figure 3. Global Zebrafish Disease Models Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Zebrafish Disease Models Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Zebrafish Disease Models Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Zebrafish Disease Models Revenue in 2021
Figure 8. By Type - Global Zebrafish Disease Models Revenue Market Share, 2017-2028
Figure 9. By Application - Global Zebrafish Disease Models Revenue Market Share, 2017-2028
Figure 10. By Region - Global Zebrafish Disease Models Revenue Market Share, 2017-2028
Figure 11. By Country - North America Zebrafish Disease Models Revenue Market Share, 2017-2028
Figure 12. US Zebrafish Disease Models Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Zebrafish Disease Models Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Zebrafish Disease Models Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Zebrafish Disease Models Revenue Market Share, 2017-2028
Figure 16. Germany Zebrafish Disease Models Revenue, (US$, Mn), 2017-2028
Figure 17. France Zebrafish Disease Models Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Zebrafish Disease Models Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Zebrafish Disease Models Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Zebrafish Disease Models Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Zebrafish Disease Models Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Zebrafish Disease Models Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Zebrafish Disease Models Revenue Market Share, 2017-2028
Figure 24. China Zebrafish Disease Models Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Zebrafish Disease Models Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Zebrafish Disease Models Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Zebrafish Disease Models Revenue, (US$, Mn), 2017-2028
Figure 28. India Zebrafish Disease Models Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Zebrafish Disease Models Revenue Market Share, 2017-2028
Figure 30. Brazil Zebrafish Disease Models Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Zebrafish Disease Models Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Zebrafish Disease Models Revenue Market Share, 2017-2028
Figure 33. Turkey Zebrafish Disease Models Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Zebrafish Disease Models Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Zebrafish Disease Models Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Zebrafish Disease Models Revenue, (US$, Mn), 2017-2028
Figure 37. Shanghai Model Organisms Center, Inc. Zebrafish Disease Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. ZeClinics Zebrafish Disease Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. InVivo Biosystems Zebrafish Disease Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Biobide Zebrafish Disease Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pentagrit Zebrafish Disease Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Evotec Zebrafish Disease Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Aurigene Pharmaceutical Services Zebrafish Disease Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Ikan Biotech Zebrafish Disease Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bioreperia Zebrafish Disease Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Hangzhou Hunter Biotechnology Co., Ltd. Zebrafish Disease Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. YSY BIOTECH Zebrafish Disease Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Eze-Rinka Zebrafish Disease Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. INVENesis Zebrafish Disease Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. FEIFAN TEST Zebrafish Disease Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Charles River Laboratories Zebrafish Disease Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)